birabresib
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for birabresib, covering 2018-05-17 to 2019-07-23. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Hematologic Malignancies (MK-8628-005) [Phase 1]